Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q1 2026 Earnings

19MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.58

-0.44

-0.29

-0.15

Details

Expected EPS

-0.148625

Actual EPS

-0.27

Surprise EPS

-0.12

Surprise Percent

+81.67%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.27 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.